Cargando…
Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine against Retinoblastoma Cells
Treatment trends of retinoblastoma (RB) have gradually evolved from eye enucleation and external radiation to local treatment. Combined treatment with an oncolytic virus and chemotherapy is currently a new method in RB treatment. To investigate the therapeutic effect of oncolytic adenovirus SG600 in...
Autores principales: | Song, Xin, Wang, Haibo, Jia, Renbing, Cun, Biyun, Zhao, Xiaoping, Zhou, Yixiong, Xu, Xiaofang, Qian, Guanxiang, Ge, Shengfang, Fan, Xianqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472711/ https://www.ncbi.nlm.nih.gov/pubmed/23109819 http://dx.doi.org/10.3390/ijms130910736 |
Ejemplares similares
-
Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021) -
Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors
por: Huang, Xiaolin, et al.
Publicado: (2012) -
LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020) -
Publication Trends of Research on Retinoblastoma During 2001–2021: A 20-Year Bibliometric Analysis
por: Gu, Xiang, et al.
Publicado: (2021) -
A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors
por: Yao, Yuting, et al.
Publicado: (2012)